AC Immune (ACIU) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for AC Immune (ACIU) over the last 12 years, with Q3 2025 value amounting to $135.6 million.
- AC Immune's Cash & Current Investments fell 2559.79% to $135.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.6 million, marking a year-over-year decrease of 2559.79%. This contributed to the annual value of $188.9 million for FY2024, which is 9931.97% down from last year.
- Per AC Immune's latest filing, its Cash & Current Investments stood at $135.6 million for Q3 2025, which was down 2559.79% from $153.6 million recorded in Q2 2025.
- Over the past 5 years, AC Immune's Cash & Current Investments peaked at $125.9 billion during Q4 2021, and registered a low of -$32.8 million during Q2 2021.
- Over the past 5 years, AC Immune's median Cash & Current Investments value was $135.6 million (recorded in 2025), while the average stood at $12.0 billion.
- The largest annual percentage gain for AC Immune's Cash & Current Investments in the last 5 years was 5951971.46% (2021), contrasted with its biggest fall of 11685.16% (2021).
- Over the past 5 years, AC Immune's Cash & Current Investments (Quarter) stood at $125.9 billion in 2021, then plummeted by 99.9% to $127.2 million in 2022, then soared by 21723.36% to $27.8 billion in 2023, then plummeted by 99.32% to $188.9 million in 2024, then fell by 28.22% to $135.6 million in 2025.
- Its Cash & Current Investments was $135.6 million in Q3 2025, compared to $153.6 million in Q2 2025 and $162.0 million in Q1 2025.